🇨🇭September 23, 2026·10h agoIndustry

Change in Roche’s Board of Directors

Publisher

Roche Newsroom

Switzerland

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: Roche Newsroom
Region: Switzerland
Scope: Industry
Published: September 23, 2026

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on roche.com

Leave the platform to read the original full article on the publisher site.

Source: Roche Newsroom

Scope: Industry

Open original article

Related coverage

More related coverage

Interpharma Switzerland/8h ago

Medienmitteilung: Die Bevölkerung erwartet einen besseren Zugang zu innovativen Medikamenten

Roche Newsroom/10h ago

Positive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)

Hyman, Phelps & McNamara (FDA Law)/13h ago

T Time: Women Were First to Put Testosterone Back on FDA’s Agenda. Now It’s Industry’s Turn

Natco Pharma/15h ago

natco records %e2%82%b9816 9 crore consolidated revenue and %e2%82%b9269 0 crore of profit after tax for q4 fy26 and %e2%82%b94375 9 crore of revenue %e2%82%b91418 5 crore profit after tax for fy26